Cargando…

Beyond Rheumatoid Arthritis Evaluation: What are We Missing?

Rheumatoid Arthritis (RA) is a chronic inflammatory autoimmune systemic disease that preferentially affects small and large joints with a progressive course and can become deforming and disabling. In recent years, much progress has been made in the evaluation of inflammation and disease activity, ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espinoza, Gianna, Maldonado, Genessis, Narvaez, Jemina, Guerrero, Roberto, Citera, Gustavo, Rios, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007602/ https://www.ncbi.nlm.nih.gov/pubmed/33790666 http://dx.doi.org/10.2147/OARRR.S298393

Ejemplares similares

Vitamin D Megadose: Definition, Efficacy in Bone Metabolism, Risk of Falls and Fractures
por: Narvaez, Jemina, et al.
Publicado: (2020)

d-Dimer trend in a long-term rheumatoid arthritis patient with tofacitinib treatment and recent COVID-19 infection
por: Maldonado, Genessis, et al.
Publicado: (2022)

Functional Disability and Its Determinants in Ecuadorian Patients with Rheumatoid Arthritis
por: Intriago, Maria, et al.
Publicado: (2020)

Quality of life in Ecuadorian patients with established rheumatoid arthritis
por: Intriago, Maria, et al.
Publicado: (2019)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos, Carlos, et al.
Publicado: (2017)

Rheumatologists in Ecuador: Results of a Survey
por: Maldonado, Genessis, et al.
Publicado: (2020)

Autoinflammatory/Autoimmunity Syndrome Induced By Adjuvants (ASIA) Due to Silicone Incompatibility Syndrome
por: Maldonado, Genessis, et al.
Publicado: (2021)

Genetics of rheumatoid arthritis: what have we learned?
por: Bax, Marieke, et al.
Publicado: (2011)

Rheumatoid Arthritis and Malignancy: What Should We Do With DMARDs?
por: Jeon, Chan Hong
Publicado: (2022)

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
por: Weinblatt, Michael E, et al.
Publicado: (2013)

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
por: Schiff, Michael, et al.
Publicado: (2014)

Are we missing the diagnosis of depression in patients with rheumatoid arthritis at a tertiary care facility?
por: Masood, Ammara, et al.
Publicado: (2017)

Work Productivity in Rheumatoid Arthritis: Relationship with Clinical and Radiological Features
por: Chaparro del Moral, Rafael, et al.
Publicado: (2012)

Predicting the outcomes of preterm neonates beyond the neonatal intensive care unit: What are we missing?
por: Crilly, Colin J., et al.
Publicado: (2020)

Anesthesiologists and burnout: what are we missing?
por: Bansal, Priyanka, et al.
Publicado: (2021)

Nailfold capillaroscopy in diabetes mellitus: a case of neo-angiogenesis after achieving normoglycemia
por: Maldonado, Genessis, et al.
Publicado: (2022)

Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?
por: Mongin, Denis, et al.
Publicado: (2019)

Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis
por: Maranini, Beatrice, et al.
Publicado: (2022)

Retinal Glaucoma Public Datasets: What Do We Have and What Is Missing?
por: Camara, José, et al.
Publicado: (2022)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014)

Genetics of rheumatoid arthritis: GWAS and beyond
por: McAllister, Kate, et al.
Publicado: (2011)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
por: Paroli, Marino, et al.
Publicado: (2023)

The Diversity of Coral Reefs: What Are We Missing?
por: Plaisance, Laetitia, et al.
Publicado: (2011)

Proteinuria is common among HIV patients: what are we missing?
por: Antonello, Vicente Sperb, et al.
Publicado: (2015)

Clinical Characteristics in Patients with Rheumatoid Arthritis: Differences between Genders
por: Intriago, M., et al.
Publicado: (2019)

Are we ready? What is missing and what is needed? A regulator’s perspective
por: Bernardini, Claudia, et al.
Publicado: (2014)

The empirical study of norms is just what we are missing
por: Achourioti, Theodora, et al.
Publicado: (2014)

Global Epidemiology of Mental Disorders: What Are We Missing?
por: Baxter, Amanda J., et al.
Publicado: (2013)

Repositories for Taxonomic Data: Where We Are and What is Missing
por: Miralles, Aurélien, et al.
Publicado: (2020)

COVID-19 and the young heart: what are we missing?
por: Spencer, Robert, et al.
Publicado: (2020)

Biomarkers in Rheumatoid Arthritis, what is new?
por: Gavrilă, BI, et al.
Publicado: (2016)

Distinguishing rheumatoid arthritis from psoriatic arthritis
por: Merola, Joseph F, et al.
Publicado: (2018)

Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study
por: Pierini, Florencia S., et al.
Publicado: (2021)

50 States or 50 Countries: What Did We Miss and What Do We Do Now?
por: Burkle, Frederick M., et al.
Publicado: (2020)

Rheumatoid Arthritis in Minorities
por: Anaya, Juan-Manuel, et al.
Publicado: (2013)

Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing?
por: Gieseg, Steven P., et al.
Publicado: (2018)

Proliferative Signals in Chronic Lymphocytic Leukemia; What Are We Missing?
por: Haselager, Marco V., et al.
Publicado: (2020)

Dry eye disease revisited: What have we missed?
por: Sun, Chi-Chin
Publicado: (2019)

COVID-19 follow-up planning: what will we be missing?
por: Lee, Lydia, et al.
Publicado: (2020)

Eosinopenia in COVID-19: What we missed so far?
por: Davido, Benjamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ib64n934jtj9dj07oasi12621g